Coronary Artery Disease in Persons With Human Immunodeficiency Virus Without Detectable Viral Replication

Andreas D Knudsen1,2, Andreas Fuchs2, Thomas Benfield3

  • 1Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

PubMed

Insights

Nearly half of people with HIV (PWH) without viral replication had coronary artery disease (CAD). Inflammatory markers like IL-6 and hsCRP were linked to CAD, but this association weakened after considering traditional risk factors.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Coronary artery disease (CAD) is a significant concern in people with human immunodeficiency virus (HIV).
  • Understanding the role of inflammation in CAD development among PWH is crucial for risk stratification and management.
  • Previous research suggests a potential link between inflammatory markers and cardiovascular complications in HIV-infected individuals.

Purpose of the Study:

  • To determine the prevalence of CAD in virologically suppressed people with HIV (PWH).
  • To investigate the association between inflammatory markers (IL-6, IL-1β, hsCRP) and CAD in PWH.
  • To explore the role of inflammation in mediating the relationship between traditional cardiovascular risk factors and CAD in this population.

Main Methods:

  • The study analyzed data from the Copenhagen Comorbidity in HIV Infection (COCOMO) study.
  • Participants included virologically suppressed PWH who underwent coronary computed tomographic (CT) angiography.
  • Atherosclerosis was defined as >0% stenosis, and obstructive CAD as ≥50% stenosis. Inflammatory markers and traditional risk factors were assessed.

Main Results:

  • Among 669 PWH (mean age 51 years, 89% male), 45% had atherosclerosis and 18% had obstructive CAD.
  • Traditional risk factors (age, male sex, hypertension, diabetes, smoking, dyslipidemia, time with HIV, protease inhibitor use) were associated with CAD.
  • Elevated IL-6 and hsCRP levels showed an association with CAD in univariable analyses, but this was not significant after adjusting for traditional risk factors.

Conclusions:

  • A substantial proportion of virologically suppressed PWH exhibit angiographically verified atherosclerosis.
  • While inflammatory markers IL-6 and hsCRP were associated with CAD in initial analyses, this link was diminished when accounting for established cardiovascular risk factors.
  • Inflammation may play a mediating role in the development of CAD driven by traditional risk factors in the PWH population.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K